


Heidelberg Pharma
Biotechnology Research • Gregor-Mendel-Straße 22, Ladenburg, Germany • 51-100 Employees
Company overview
| Headquarters | Gregor-Mendel-Straße 22, Ladenburg, Baden-Württemberg 68526, DE |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Onkologie, ADC, Atac, Amanitin |
| Employees | 51-100 |
| Socials |
Key Contacts at Heidelberg Pharma
Annalisa Zuccotti
Associate Director Business Development
Claudia Wall
Senior Director Cmc Development & Drug Supply
Alastair Sword
Interim Biometrics Director
Sarah-Jane Neuberth
Associate Director In Vivo Biology
Andreas Pahl
Ceo & Sprecher Des Vorstands At Heidelberg Pharma Ag
Wolfgang Flasche
Director Intellectual Property
Anette Last
Associate Director Clinical Operations
Martina Meierhold
Director Regulatory Affairs
Daniela Schleif
Director Project&Portfoliomanagement
Heidelberg Pharma Email Formats
Heidelberg Pharma uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@hdpharma.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@hdpharma.com | 100% |
About Heidelberg Pharma
Heidelberg Pharma is a biopharmaceutical company working on a new treatment approach in oncology and developing novel drugs based on its ADC technologies for the targeted and highly effective treatment of cancer. ADCs are antibody-drug conjugates that combine the specificity of antibodies with the efficacy of toxins to fight cancer. Selected antibodies are loaded with cytotoxic compounds, the so-called payloads, that are transported into diseased cells. Inside the cells, the toxins then unleash their effect and kill the diseased cells. Heidelberg Pharma uses several compounds and has built up an ADC toolbox that overcomes tumor resistance via numerous pathways and addresses different types of cancer using various antibodies. The goal is to develop targeted and highly effective ADCs for the treatment of a variety of malignant hematologic and solid tumors. The company is listed on the Frankfurt Stock Exchange (FSE: HPHA). More information is available at www.heidelberg-pharma.com.
Heidelberg Pharma revenue & valuation
| Annual revenue | $3,500,000 |
| Revenue per employee | $65,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Heidelberg Pharma has 22 employees across 11 departments.
Departments
Number of employees
Funding Data
Heidelberg Pharma has never raised funding before.
Heidelberg Pharma Tech Stack
Discover the technologies and tools that power Heidelberg Pharma's digital infrastructure, from frameworks to analytics platforms.
Web servers
CMS
Search engines
UI frameworks
Programming languages
Security
Recruitment & staffing
Frequently asked questions
4.8
40,000 users



